| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MHC class I receptor activity | 7.13e-17 | 18 | 54 | 8 | GO:0032393 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 2.94e-16 | 6 | 54 | 6 | GO:0030109 | |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 5.53e-16 | 12 | 54 | 7 | GO:0032396 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 1.20e-13 | 5 | 54 | 5 | GO:0030107 | |
| GeneOntologyMolecularFunction | IgM binding | 1.34e-13 | 11 | 54 | 6 | GO:0001791 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 2.30e-12 | 16 | 54 | 6 | GO:0023029 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 2.50e-12 | 7 | 54 | 5 | GO:0023025 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 7.75e-12 | 19 | 54 | 6 | GO:0032394 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 5.38e-10 | 36 | 54 | 6 | GO:0019865 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 5.44e-09 | 52 | 54 | 6 | GO:0042169 | |
| GeneOntologyMolecularFunction | MHC protein binding | 1.07e-08 | 58 | 54 | 6 | GO:0042287 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.07e-08 | 102 | 54 | 7 | GO:0001540 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.38e-08 | 165 | 54 | 8 | GO:0140375 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.28e-08 | 32 | 54 | 5 | GO:0042288 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 3.65e-08 | 35 | 54 | 5 | GO:0008157 | |
| GeneOntologyMolecularFunction | coreceptor activity | 4.00e-08 | 72 | 54 | 6 | GO:0015026 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 8.33e-08 | 41 | 54 | 5 | GO:0023023 | |
| GeneOntologyMolecularFunction | amide binding | 1.32e-06 | 299 | 54 | 8 | GO:0033218 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.50e-06 | 210 | 54 | 7 | GO:0019903 | |
| GeneOntologyMolecularFunction | peptide binding | 2.09e-06 | 318 | 54 | 8 | GO:0042277 | |
| GeneOntologyMolecularFunction | phosphatase binding | 6.80e-06 | 264 | 54 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | protein domain specific binding | LILRA1 PPARGC1B LILRA2 SYNJ1 SYNJ2 LILRB2 SKAP1 SCNN1A APOBEC1 LILRB1 LILRB5 | 1.83e-05 | 875 | 54 | 11 | GO:0019904 |
| GeneOntologyMolecularFunction | phosphoglucomutase activity | 2.15e-05 | 3 | 54 | 2 | GO:0004614 | |
| GeneOntologyMolecularFunction | intramolecular transferase activity | 6.50e-05 | 29 | 54 | 3 | GO:0016866 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity | 1.07e-04 | 6 | 54 | 2 | GO:0043813 | |
| GeneOntologyMolecularFunction | inositol-1,4,5-trisphosphate 5-phosphatase activity | 1.99e-04 | 8 | 54 | 2 | GO:0052658 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity | 3.19e-04 | 10 | 54 | 2 | GO:0004439 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 4-phosphatase activity | 3.19e-04 | 10 | 54 | 2 | GO:0034596 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity | 3.89e-04 | 11 | 54 | 2 | GO:0052629 | |
| GeneOntologyMolecularFunction | intramolecular phosphotransferase activity | 3.89e-04 | 11 | 54 | 2 | GO:0016868 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate phosphatase activity | 4.66e-04 | 12 | 54 | 2 | GO:0106019 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 5-phosphatase activity | 5.49e-04 | 13 | 54 | 2 | GO:0034595 | |
| GeneOntologyMolecularFunction | inositol trisphosphate phosphatase activity | 6.40e-04 | 14 | 54 | 2 | GO:0046030 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 6.40e-04 | 14 | 54 | 2 | GO:0004438 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 7.37e-04 | 15 | 54 | 2 | GO:0052744 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 8.41e-04 | 16 | 54 | 2 | GO:0106018 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | LILRA1 LILRB3 LILRA2 LILRB2 GPR182 CLEC1B TACR3 KIR3DL1 KIR3DS1 LILRB1 LILRB5 | 8.50e-04 | 1353 | 54 | 11 | GO:0004888 |
| GeneOntologyMolecularFunction | inositol phosphate phosphatase activity | 1.32e-03 | 20 | 54 | 2 | GO:0052745 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 1.85e-03 | 656 | 54 | 7 | GO:0008047 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 2.41e-03 | 27 | 54 | 2 | GO:0034593 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 2.97e-03 | 30 | 54 | 2 | GO:0052866 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.41e-03 | 599 | 54 | 6 | GO:0050839 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 6.83e-03 | 143 | 54 | 3 | GO:0017124 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic depression | 2.41e-10 | 14 | 56 | 5 | GO:1900454 | |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic depression | 3.98e-09 | 23 | 56 | 5 | GO:1900452 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell differentiation | 1.15e-08 | 28 | 56 | 5 | GO:0043011 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.23e-08 | 59 | 56 | 6 | GO:0045671 | |
| GeneOntologyBiologicalProcess | interleukin-10-mediated signaling pathway | 1.59e-08 | 11 | 56 | 4 | GO:0140105 | |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 1.66e-08 | 62 | 56 | 6 | GO:0035306 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 2.74e-08 | 116 | 56 | 7 | GO:0045670 | |
| GeneOntologyBiologicalProcess | dephosphorylation | LILRA1 PPARGC1B LILRA2 SYNJ1 SYNJ2 PTPRS LILRB2 VCAN LILRB1 LILRB5 | 2.86e-08 | 347 | 56 | 10 | GO:0016311 |
| GeneOntologyBiologicalProcess | regulation of dephosphorylation | 5.41e-08 | 128 | 56 | 7 | GO:0035303 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 1.13e-07 | 85 | 56 | 6 | GO:0002762 | |
| GeneOntologyBiologicalProcess | long-term synaptic depression | 1.23e-07 | 44 | 56 | 5 | GO:0060292 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell activation | 1.55e-07 | 46 | 56 | 5 | GO:0001773 | |
| GeneOntologyBiologicalProcess | B cell homeostasis | 1.92e-07 | 48 | 56 | 5 | GO:0001782 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 2.72e-07 | 162 | 56 | 7 | GO:0030316 | |
| GeneOntologyBiologicalProcess | dendritic cell differentiation | 3.51e-07 | 54 | 56 | 5 | GO:0097028 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | 5.97e-07 | 182 | 56 | 7 | GO:0002761 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | LILRA1 LILRB3 LILRA2 PTPRS LILRB2 SKAP1 LILRA6 KIR3DL1 KIR3DS1 LILRB1 LILRB5 | 6.67e-07 | 615 | 56 | 11 | GO:0002764 |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic potentiation | 1.04e-06 | 67 | 56 | 5 | GO:1900271 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell differentiation | 1.67e-06 | 134 | 56 | 6 | GO:0045638 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 2.53e-06 | 80 | 56 | 5 | GO:0050805 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 3.35e-06 | 151 | 56 | 6 | GO:1902106 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 4.51e-06 | 159 | 56 | 6 | GO:1903707 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | 5.77e-06 | 256 | 56 | 7 | GO:0006470 | |
| GeneOntologyBiologicalProcess | lymphocyte homeostasis | 9.21e-06 | 104 | 56 | 5 | GO:0002260 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 1.24e-05 | 288 | 56 | 7 | GO:0045637 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte differentiation | 2.08e-05 | 312 | 56 | 7 | GO:0002573 | |
| GeneOntologyBiologicalProcess | long-term synaptic potentiation | 4.44e-05 | 144 | 56 | 5 | GO:0060291 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 4.57e-05 | 353 | 56 | 7 | GO:0010721 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 5.10e-05 | 244 | 56 | 6 | GO:0019724 | |
| GeneOntologyBiologicalProcess | leukocyte homeostasis | 5.92e-05 | 153 | 56 | 5 | GO:0001776 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated inhibitory signaling pathway | 7.20e-05 | 5 | 56 | 2 | GO:0002774 | |
| GeneOntologyBiologicalProcess | adaptive immune response | LILRA1 LILRB3 LILRA2 LILRB2 IGHV1-45 SKAP1 LILRA6 TRBV2 LILRB1 LILRB5 | 7.58e-05 | 838 | 56 | 10 | GO:0002250 |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | 1.24e-04 | 558 | 56 | 8 | GO:0030099 | |
| GeneOntologyBiologicalProcess | regulation of immune response | LILRA1 LILRB3 LILRA2 PTPRS LILRB2 SKAP1 LILRA6 KIR3DL1 KIR3DS1 LILRB1 LILRB5 | 1.36e-04 | 1085 | 56 | 11 | GO:0050776 |
| GeneOntologyBiologicalProcess | cognition | 1.42e-04 | 423 | 56 | 7 | GO:0050890 | |
| GeneOntologyBiologicalProcess | regulation of cell development | LILRA1 PPARGC1B LILRB3 LILRA2 SYNJ1 SPINT1 PTPRS LILRB2 VCAN LILRB1 LILRB5 | 1.48e-04 | 1095 | 56 | 11 | GO:0060284 |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 1.54e-04 | 429 | 56 | 7 | GO:1902105 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 2.04e-04 | 449 | 56 | 7 | GO:0002449 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | 2.25e-04 | 320 | 56 | 6 | GO:0002274 | |
| GeneOntologyBiologicalProcess | immune response-inhibiting cell surface receptor signaling pathway | 3.21e-04 | 10 | 56 | 2 | GO:0002767 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 4.21e-04 | 233 | 56 | 5 | GO:0050806 | |
| GeneOntologyBiologicalProcess | immune response-inhibiting signal transduction | 4.70e-04 | 12 | 56 | 2 | GO:0002765 | |
| GeneOntologyBiologicalProcess | learning or memory | 5.09e-04 | 373 | 56 | 6 | GO:0007611 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 6.19e-04 | 540 | 56 | 7 | GO:1903706 | |
| GeneOntologyBiologicalProcess | regulation of dendritic cell differentiation | 8.48e-04 | 16 | 56 | 2 | GO:2001198 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | 9.05e-04 | 576 | 56 | 7 | GO:0002443 | |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | 9.14e-04 | 577 | 56 | 7 | GO:0019221 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 1.18e-03 | 293 | 56 | 5 | GO:0048167 | |
| GeneOntologyBiologicalProcess | negative regulation of interferon-beta production | 1.33e-03 | 20 | 56 | 2 | GO:0032688 | |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | 1.53e-03 | 631 | 56 | 7 | GO:0002683 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.54e-03 | 462 | 56 | 6 | GO:0002460 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-3-phosphate biosynthetic process | 1.62e-03 | 22 | 56 | 2 | GO:0036092 | |
| GeneOntologyCellularComponent | Fc-epsilon receptor I complex | 2.09e-14 | 9 | 55 | 6 | GO:0032998 | |
| GeneOntologyCellularComponent | Fc receptor complex | 2.29e-13 | 12 | 55 | 6 | GO:0032997 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | LILRA1 LILRB3 LILRA2 CATSPERE SYNJ1 LILRB2 SKAP1 TRBV2 LILRB1 LILRB5 PGM5 | 5.16e-06 | 785 | 55 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | side of membrane | 4.26e-04 | 875 | 55 | 9 | GO:0098552 | |
| GeneOntologyCellularComponent | membrane protein complex | LILRA1 LILRB3 LILRA2 CATSPERE SYNJ1 LILRB2 SKAP1 SCNN1A TRBV2 LILRB1 LILRB5 PGM5 | 4.28e-04 | 1498 | 55 | 12 | GO:0098796 |
| MousePheno | decreased length of allograft survival | 1.85e-11 | 9 | 40 | 5 | MP:0004752 | |
| MousePheno | abnormal visual cortex morphology | 6.32e-10 | 16 | 40 | 5 | MP:0000805 | |
| MousePheno | abnormal occipital lobe morphology | 1.23e-09 | 18 | 40 | 5 | MP:0000804 | |
| MousePheno | abnormal dendritic cell differentiation | 2.22e-09 | 20 | 40 | 5 | MP:0008115 | |
| MousePheno | increased B-1 B cell number | 6.62e-07 | 59 | 40 | 5 | MP:0004977 | |
| MousePheno | abnormal response to transplant | 9.98e-07 | 64 | 40 | 5 | MP:0005671 | |
| MousePheno | abnormal T-helper 2 physiology | 1.26e-06 | 67 | 40 | 5 | MP:0005466 | |
| MousePheno | increased B cell proliferation | 2.21e-06 | 75 | 40 | 5 | MP:0005154 | |
| MousePheno | abnormal CD4-positive, alpha-beta T cell physiology | 6.80e-06 | 165 | 40 | 6 | MP:0005463 | |
| MousePheno | abnormal B-1 B cell number | 2.40e-05 | 122 | 40 | 5 | MP:0004976 | |
| MousePheno | abnormal B-1 B cell morphology | 2.50e-05 | 123 | 40 | 5 | MP:0004940 | |
| MousePheno | abnormal dendritic cell morphology | 5.15e-05 | 143 | 40 | 5 | MP:0005461 | |
| MousePheno | abnormal B cell proliferation | 6.89e-05 | 152 | 40 | 5 | MP:0005153 | |
| MousePheno | abnormal B cell activation | 1.05e-04 | 166 | 40 | 5 | MP:0008217 | |
| MousePheno | increased mature B cell number | 1.11e-04 | 168 | 40 | 5 | MP:0008210 | |
| MousePheno | abnormal cerebral cortex morphology | 3.12e-04 | 328 | 40 | 6 | MP:0000788 | |
| MousePheno | intestinal edema | 5.17e-04 | 12 | 40 | 2 | MP:0003288 | |
| MousePheno | abnormal mature B cell morphology | 6.21e-04 | 244 | 40 | 5 | MP:0008171 | |
| Domain | ig | LILRA1 LILRB3 LILRA2 PTPRS LILRA6 KIR3DL1 KIR3DS1 LILRB1 LILRB5 | 2.91e-09 | 190 | 53 | 9 | PF00047 |
| Domain | Immunoglobulin | LILRA1 LILRB3 LILRA2 PTPRS LILRA6 KIR3DL1 KIR3DS1 LILRB1 LILRB5 | 2.91e-09 | 190 | 53 | 9 | IPR013151 |
| Domain | Ig-like_dom | FAM187B LILRA1 LILRB3 LILRA2 PTPRS LILRB2 VCAN LILRA6 KIR3DL1 KIR3DS1 LILRB1 LILRB5 | 1.25e-08 | 503 | 53 | 12 | IPR007110 |
| Domain | IG | LILRA1 LILRB3 LILRA2 PTPRS LILRB2 VCAN LILRA6 KIR3DL1 KIR3DS1 LILRB1 LILRB5 | 2.18e-08 | 421 | 53 | 11 | SM00409 |
| Domain | Ig_sub | LILRA1 LILRB3 LILRA2 PTPRS LILRB2 VCAN LILRA6 KIR3DL1 KIR3DS1 LILRB1 LILRB5 | 2.18e-08 | 421 | 53 | 11 | IPR003599 |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 4.29e-07 | 6 | 53 | 3 | IPR016332 | |
| Domain | Ig-like_fold | FAM187B LILRA1 LILRB3 LILRA2 PTPRS LILRB2 VCAN LILRA6 KIR3DL1 KIR3DS1 LILRB1 LILRB5 | 4.98e-07 | 706 | 53 | 12 | IPR013783 |
| Domain | IG_LIKE | LILRA1 LILRB3 LILRA2 PTPRS LILRB2 VCAN LILRA6 KIR3DL1 LILRB1 LILRB5 | 1.02e-06 | 491 | 53 | 10 | PS50835 |
| Domain | DUF1866 | 7.90e-06 | 2 | 53 | 2 | IPR015047 | |
| Domain | DUF1866 | 7.90e-06 | 2 | 53 | 2 | SM01165 | |
| Domain | DUF1866 | 7.90e-06 | 2 | 53 | 2 | PF08952 | |
| Domain | PGM_PMM_III | 4.72e-05 | 4 | 53 | 2 | PF02880 | |
| Domain | A-D-PHexomutase_CS | 4.72e-05 | 4 | 53 | 2 | IPR016066 | |
| Domain | A-D-PHexomutase_a/b/a-III | 4.72e-05 | 4 | 53 | 2 | IPR005846 | |
| Domain | Ig_2 | 5.44e-05 | 73 | 53 | 4 | PF13895 | |
| Domain | Syja_N | 7.86e-05 | 5 | 53 | 2 | PF02383 | |
| Domain | - | 7.86e-05 | 5 | 53 | 2 | 3.30.310.50 | |
| Domain | SAC | 7.86e-05 | 5 | 53 | 2 | PS50275 | |
| Domain | PGM_PMM | 7.86e-05 | 5 | 53 | 2 | PS00710 | |
| Domain | PGM_PMM_II | 7.86e-05 | 5 | 53 | 2 | PF02879 | |
| Domain | SAC_dom | 7.86e-05 | 5 | 53 | 2 | IPR002013 | |
| Domain | PGM_PMM_I | 7.86e-05 | 5 | 53 | 2 | PF02878 | |
| Domain | PGM_PMM_IV | 7.86e-05 | 5 | 53 | 2 | PF00408 | |
| Domain | - | 7.86e-05 | 5 | 53 | 2 | 3.40.120.10 | |
| Domain | A-D-PHexomutase_a/b/a-I | 7.86e-05 | 5 | 53 | 2 | IPR005844 | |
| Domain | A-D-PHexomutase_a/b/a-II | 7.86e-05 | 5 | 53 | 2 | IPR005845 | |
| Domain | A-D-PHexomutase_C | 7.86e-05 | 5 | 53 | 2 | IPR005843 | |
| Domain | Alpha-D-phosphohexomutase_SF | 7.86e-05 | 5 | 53 | 2 | IPR005841 | |
| Domain | A-D-PHexomutase_a/b/a-I/II/III | 7.86e-05 | 5 | 53 | 2 | IPR016055 | |
| Domain | - | FAM187B LILRA1 LILRA2 PTPRS VCAN KIR3DL1 KIR3DS1 LILRB1 LILRB5 | 9.28e-05 | 663 | 53 | 9 | 2.60.40.10 |
| Domain | - | 1.12e-04 | 391 | 53 | 7 | 2.30.29.30 | |
| Domain | PH_dom-like | 1.91e-04 | 426 | 53 | 7 | IPR011993 | |
| Domain | FERM_M | 3.00e-04 | 46 | 53 | 3 | PF00373 | |
| Domain | IPPc | 3.50e-04 | 10 | 53 | 2 | IPR000300 | |
| Domain | IPPc | 3.50e-04 | 10 | 53 | 2 | SM00128 | |
| Domain | FERM_central | 3.62e-04 | 49 | 53 | 3 | IPR019748 | |
| Domain | FERM_domain | 3.62e-04 | 49 | 53 | 3 | IPR000299 | |
| Domain | - | 3.62e-04 | 49 | 53 | 3 | 1.20.80.10 | |
| Domain | FERM_1 | 3.85e-04 | 50 | 53 | 3 | PS00660 | |
| Domain | FERM_2 | 3.85e-04 | 50 | 53 | 3 | PS00661 | |
| Domain | Band_41_domain | 3.85e-04 | 50 | 53 | 3 | IPR019749 | |
| Domain | B41 | 3.85e-04 | 50 | 53 | 3 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 3.85e-04 | 50 | 53 | 3 | IPR014352 | |
| Domain | FERM_3 | 3.85e-04 | 50 | 53 | 3 | PS50057 | |
| Domain | IGc2 | 5.30e-04 | 235 | 53 | 5 | SM00408 | |
| Domain | Ig_sub2 | 5.30e-04 | 235 | 53 | 5 | IPR003598 | |
| Domain | Lectin_C | 1.75e-03 | 84 | 53 | 3 | PF00059 | |
| Domain | CLECT | 1.75e-03 | 84 | 53 | 3 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 1.81e-03 | 85 | 53 | 3 | PS50041 | |
| Domain | C-type_lectin-like | 1.87e-03 | 86 | 53 | 3 | IPR001304 | |
| Domain | - | 2.46e-03 | 26 | 53 | 2 | 3.60.10.10 | |
| Domain | FERM_C | 2.46e-03 | 26 | 53 | 2 | PF09380 | |
| Domain | Exo_endo_phos | 2.46e-03 | 26 | 53 | 2 | PF03372 | |
| Domain | - | 2.64e-03 | 97 | 53 | 3 | 3.10.100.10 | |
| Domain | Endo/exonuclease/phosphatase | 2.65e-03 | 27 | 53 | 2 | IPR005135 | |
| Domain | FERM_C | 2.65e-03 | 27 | 53 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 2.65e-03 | 27 | 53 | 2 | IPR018980 | |
| Domain | C-type_lectin-like/link | 2.79e-03 | 99 | 53 | 3 | IPR016186 | |
| Domain | CTDL_fold | 3.48e-03 | 107 | 53 | 3 | IPR016187 | |
| Domain | RRM_dom | 3.91e-03 | 227 | 53 | 4 | IPR000504 | |
| Domain | FERM_N | 3.94e-03 | 33 | 53 | 2 | IPR018979 | |
| Domain | FERM_N | 3.94e-03 | 33 | 53 | 2 | PF09379 | |
| Domain | PH | 4.03e-03 | 229 | 53 | 4 | PF00169 | |
| Domain | RRM | 4.09e-03 | 230 | 53 | 4 | PS50102 | |
| Domain | - | 5.04e-03 | 244 | 53 | 4 | 3.30.70.330 | |
| Domain | LDLR_class-A_CS | 5.75e-03 | 40 | 53 | 2 | IPR023415 | |
| Domain | Nucleotide-bd_a/b_plait | 6.13e-03 | 258 | 53 | 4 | IPR012677 | |
| Domain | Ldl_recept_a | 7.23e-03 | 45 | 53 | 2 | PF00057 | |
| Domain | - | 7.55e-03 | 46 | 53 | 2 | 4.10.400.10 | |
| Domain | PH | 7.94e-03 | 278 | 53 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 8.04e-03 | 279 | 53 | 4 | PS50003 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 4.04e-08 | 190 | 39 | 8 | M8240 | |
| Pathway | WP_SPINAL_CORD_INJURY | 4.67e-07 | 108 | 39 | 6 | MM15954 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | LILRA1 LILRB3 LILRA2 FBXO9 LILRB2 LILRA6 KIR3DL1 LILRB1 LILRB5 | 3.42e-04 | 828 | 39 | 9 | M1058 |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 4.43e-04 | 511 | 39 | 7 | MM15330 | |
| Pubmed | 6.24e-18 | 11 | 56 | 7 | 24052308 | ||
| Pubmed | 1.32e-17 | 6 | 56 | 6 | 30068593 | ||
| Pubmed | 9.24e-17 | 7 | 56 | 6 | 17998301 | ||
| Pubmed | 3.69e-16 | 8 | 56 | 6 | 9548455 | ||
| Pubmed | Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. | 2.76e-15 | 10 | 56 | 6 | 18802077 | |
| Pubmed | PirB regulates a structural substrate for cortical plasticity. | 9.01e-15 | 5 | 56 | 5 | 24302763 | |
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 23927735 | ||
| Pubmed | Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. | 9.01e-15 | 5 | 56 | 5 | 18787130 | |
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 34437845 | ||
| Pubmed | Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus. | 9.01e-15 | 5 | 56 | 5 | 37147336 | |
| Pubmed | Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity. | 9.01e-15 | 5 | 56 | 5 | 33653799 | |
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 34242819 | ||
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 21087927 | ||
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 20398663 | ||
| Pubmed | Structure and flexibility of the extracellular region of the PirB receptor. | 9.01e-15 | 5 | 56 | 5 | 30674550 | |
| Pubmed | Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence. | 9.01e-15 | 5 | 56 | 5 | 23152562 | |
| Pubmed | Regulation of plasmacytoid dendritic cell responses by PIR-B. | 9.01e-15 | 5 | 56 | 5 | 22948046 | |
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 9054430 | ||
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 20976309 | ||
| Pubmed | Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B. | 9.01e-15 | 5 | 56 | 5 | 10359805 | |
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 27324131 | ||
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 20881122 | ||
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 10586026 | ||
| Pubmed | Paired immunoglobulin-like receptor B regulates platelet activation. | 9.01e-15 | 5 | 56 | 5 | 25075127 | |
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 9550322 | ||
| Pubmed | Expression of PirB protein in intact and injured optic nerve and retina of mice. | 9.01e-15 | 5 | 56 | 5 | 22102155 | |
| Pubmed | Paired immunoglobulin-like receptors and their MHC class I recognition. | 9.01e-15 | 5 | 56 | 5 | 16011512 | |
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 27443384 | ||
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 23258232 | ||
| Pubmed | The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. | 9.01e-15 | 5 | 56 | 5 | 15494528 | |
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 19684158 | ||
| Pubmed | Mast cell regulation via paired immunoglobulin-like receptor PIR-B. | 9.01e-15 | 5 | 56 | 5 | 12403357 | |
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 37146940 | ||
| Pubmed | PirB functions as an intrinsic suppressor in hippocampal neural stem cells. | 9.01e-15 | 5 | 56 | 5 | 34120891 | |
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 15146181 | ||
| Pubmed | PIR-B-deficient mice are susceptible to Salmonella infection. | 5.40e-14 | 6 | 56 | 5 | 18768880 | |
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 29482582 | ||
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 28664612 | ||
| Pubmed | LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis. | 5.40e-14 | 6 | 56 | 5 | 37481670 | |
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 31727773 | ||
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 25320232 | ||
| Pubmed | HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. | 5.40e-14 | 6 | 56 | 5 | 12207326 | |
| Pubmed | Cell-Autonomous Regulation of Dendritic Spine Density by PirB. | 5.40e-14 | 6 | 56 | 5 | 27752542 | |
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 30787106 | ||
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 9824165 | ||
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 38383888 | ||
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 39095838 | ||
| Pubmed | PirB is a functional receptor for myelin inhibitors of axonal regeneration. | 5.40e-14 | 6 | 56 | 5 | 18988857 | |
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 21636572 | ||
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 27402837 | ||
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 24040397 | ||
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 28594961 | ||
| Pubmed | The p75 receptor mediates axon growth inhibition through an association with PIR-B. | 5.40e-14 | 6 | 56 | 5 | 21881600 | |
| Pubmed | 5.40e-14 | 6 | 56 | 5 | 24212998 | ||
| Pubmed | Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. | 5.40e-14 | 6 | 56 | 5 | 12021780 | |
| Pubmed | A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. | 6.54e-14 | 15 | 56 | 6 | 9144225 | |
| Pubmed | Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. | 1.89e-13 | 7 | 56 | 5 | 19658091 | |
| Pubmed | 1.89e-13 | 7 | 56 | 5 | 36510132 | ||
| Pubmed | 1.89e-13 | 7 | 56 | 5 | 19687229 | ||
| Pubmed | PirB restricts ocular-dominance plasticity in visual cortex. | 1.89e-13 | 7 | 56 | 5 | 16917027 | |
| Pubmed | The Nogo-B-PirB axis controls macrophage-mediated vascular remodeling. | 1.89e-13 | 7 | 56 | 5 | 24278366 | |
| Pubmed | A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. | 1.89e-13 | 7 | 56 | 5 | 18316626 | |
| Pubmed | 1.89e-13 | 7 | 56 | 5 | 35321392 | ||
| Pubmed | 1.89e-13 | 7 | 56 | 5 | 20844138 | ||
| Pubmed | 1.89e-13 | 7 | 56 | 5 | 27897222 | ||
| Pubmed | Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. | 1.89e-13 | 7 | 56 | 5 | 17371981 | |
| Pubmed | Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3. | 1.89e-13 | 7 | 56 | 5 | 21555536 | |
| Pubmed | Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. | 5.03e-13 | 8 | 56 | 5 | 22660330 | |
| Pubmed | 5.03e-13 | 8 | 56 | 5 | 19255189 | ||
| Pubmed | Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family. | 5.03e-13 | 8 | 56 | 5 | 9538215 | |
| Pubmed | 5.03e-13 | 8 | 56 | 5 | 21376641 | ||
| Pubmed | 5.03e-13 | 8 | 56 | 5 | 18209065 | ||
| Pubmed | NogoR1 and PirB signaling stimulates neural stem cell survival and proliferation. | 5.03e-13 | 8 | 56 | 5 | 24449409 | |
| Pubmed | VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells. | 5.03e-13 | 8 | 56 | 5 | 35210567 | |
| Pubmed | Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. | 1.13e-12 | 9 | 56 | 5 | 17420263 | |
| Pubmed | PIRs mediate innate myeloid cell memory to nonself MHC molecules. | 2.26e-12 | 10 | 56 | 5 | 32381589 | |
| Pubmed | Angiopoietin-like 2 is essential to aortic valve development in mice. | 2.97e-12 | 26 | 56 | 6 | 36414704 | |
| Pubmed | Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity. | 4.13e-12 | 11 | 56 | 5 | 21364532 | |
| Pubmed | 4.13e-12 | 11 | 56 | 5 | 20145200 | ||
| Pubmed | 4.13e-12 | 11 | 56 | 5 | 24738827 | ||
| Pubmed | 7.08e-12 | 12 | 56 | 5 | 22445338 | ||
| Pubmed | Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. | 7.08e-12 | 12 | 56 | 5 | 10611342 | |
| Pubmed | 9.02e-11 | 6 | 56 | 4 | 9079806 | ||
| Pubmed | 3.74e-10 | 24 | 56 | 5 | 15723811 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 14662864 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 21559424 | ||
| Pubmed | HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. | 1.58e-08 | 4 | 56 | 3 | 21270408 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 9382880 | ||
| Pubmed | The LILR family: modulators of innate and adaptive immune pathways in health and disease. | 3.94e-08 | 5 | 56 | 3 | 15304001 | |
| Pubmed | HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1. | 2.20e-07 | 8 | 56 | 3 | 27649529 | |
| Pubmed | 8.09e-07 | 198 | 56 | 6 | 27480124 | ||
| Pubmed | Extensive gene duplications and a large inversion characterize the human leukocyte receptor cluster. | 1.42e-06 | 14 | 56 | 3 | 10941842 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23524032 | ||
| Pubmed | Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1. | 2.55e-06 | 2 | 56 | 2 | 35192601 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19617579 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11098931 | ||
| Pubmed | Developmentally regulated alternative splicing in a novel synaptojanin. | 2.55e-06 | 2 | 56 | 2 | 9442075 | |
| Pubmed | Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. | 2.55e-06 | 2 | 56 | 2 | 36449053 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15242876 | ||
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 2.55e-06 | 2 | 56 | 2 | 33526815 | |
| Interaction | LILRA3 interactions | 1.50e-08 | 11 | 54 | 4 | int:LILRA3 | |
| Interaction | CST11 interactions | 1.71e-06 | 75 | 54 | 5 | int:CST11 | |
| Interaction | HLA-G interactions | 1.59e-05 | 118 | 54 | 5 | int:HLA-G | |
| Interaction | SDF2L1 interactions | 2.32e-05 | 322 | 54 | 7 | int:SDF2L1 | |
| Interaction | LILRA6 interactions | 4.21e-05 | 4 | 54 | 2 | int:LILRA6 | |
| Cytoband | 19q13.4 | LILRA1 LILRB3 LILRA2 LILRB2 LILRA6 KIR3DL1 KIR3DS1 LILRB1 LILRB5 | 5.86e-16 | 79 | 56 | 9 | 19q13.4 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | LENG8 FAM187B LILRA1 LILRB3 LILRA2 LILRB2 LILRA6 KIR3DL1 LILRB1 LILRB5 | 1.61e-06 | 1192 | 56 | 10 | chr19q13 |
| Cytoband | 14q24.1 | 8.47e-04 | 35 | 56 | 2 | 14q24.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 9.21e-04 | 353 | 56 | 4 | chr12p13 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 9.23e-11 | 5 | 39 | 4 | 1182 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 1.85e-07 | 6 | 39 | 3 | 1181 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.61e-06 | 394 | 39 | 8 | 471 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.70e-04 | 50 | 39 | 3 | 1293 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 6.79e-04 | 18 | 39 | 2 | 620 | |
| GeneFamily | Phosphoinositide phosphatases | 2.16e-03 | 32 | 39 | 2 | 1079 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.53e-03 | 41 | 39 | 2 | 1298 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.85e-03 | 206 | 39 | 3 | 682 | |
| Coexpression | SOUCEK_MYC_TARGETS | 4.21e-10 | 19 | 56 | 5 | MM1252 | |
| Coexpression | VALK_AML_CLUSTER_5 | 7.14e-09 | 32 | 56 | 5 | M14437 | |
| Coexpression | VILIMAS_NOTCH1_TARGETS_DN | 9.84e-09 | 34 | 56 | 5 | MM791 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_D_DN | 5.09e-08 | 94 | 56 | 6 | MM787 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 6.14e-08 | 97 | 56 | 6 | MM1016 | |
| Coexpression | DESCARTES_MAIN_FETAL_MYELOID_CELLS | 6.53e-08 | 98 | 56 | 6 | M40071 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 7.30e-08 | 50 | 56 | 5 | MM3805 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_MYELOID_CELLS | 1.35e-07 | 185 | 56 | 7 | M40148 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_8_PRECICTIVE_ICB_RESPONSE | 2.29e-07 | 200 | 56 | 7 | MM17082 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_LEUKOCYTE_AGEING | 4.02e-07 | 133 | 56 | 6 | MM3715 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | DGCR2 LILRA1 LILRA2 FRMD6 SYNJ1 LILRB2 VCAN SCNN1A CLEC1B APOBEC1 LILRB1 LILRB5 PGM1 TMEM229B | 4.82e-07 | 1316 | 56 | 14 | MM1052 |
| Coexpression | ZHENG_IL22_SIGNALING_UP | 5.34e-07 | 74 | 56 | 5 | MM762 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_MYELOID_CELLS | 5.88e-07 | 230 | 56 | 7 | M40210 | |
| Coexpression | HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN | 1.27e-06 | 258 | 56 | 7 | M41144 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_MICROGLIA | LILRA1 LILRB3 LILRA2 PLVAP LILRB2 ARHGAP12 LILRA6 LILRB1 LILRB5 | 1.38e-06 | 516 | 56 | 9 | M40168 |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 2.06e-06 | 97 | 56 | 5 | MM3789 | |
| Coexpression | DESCARTES_FETAL_LUNG_MYELOID_CELLS | 2.21e-06 | 178 | 56 | 6 | M40244 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 2.64e-06 | 102 | 56 | 5 | MM1064 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ALVEOLAR_MACROPHAGE_AGEING | 2.85e-06 | 186 | 56 | 6 | MM3762 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE | 3.27e-06 | 426 | 56 | 8 | M41019 | |
| Coexpression | GSE11057_PBMC_VS_MEM_CD4_TCELL_UP | 3.97e-06 | 197 | 56 | 6 | M3120 | |
| Coexpression | GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN | 4.33e-06 | 200 | 56 | 6 | M3091 | |
| Coexpression | GSE22886_DC_VS_MONOCYTE_DN | 4.33e-06 | 200 | 56 | 6 | M4472 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_MATURE_CELL | 4.94e-06 | 317 | 56 | 7 | MM1163 | |
| Coexpression | DESCARTES_FETAL_LIVER_MYELOID_CELLS | 5.73e-06 | 210 | 56 | 6 | M40229 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_MYELOID_CELLS | 7.09e-06 | 218 | 56 | 6 | M40221 | |
| Coexpression | DESCARTES_FETAL_CEREBELLUM_MICROGLIA | LILRA1 LILRB3 LILRA2 PLVAP LILRB2 ARHGAP12 LILRA6 LILRB1 LILRB5 | 9.21e-06 | 652 | 56 | 9 | M40157 |
| Coexpression | DESCARTES_FETAL_PANCREAS_MYELOID_CELLS | 1.14e-05 | 237 | 56 | 6 | M40264 | |
| Coexpression | HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP | 1.52e-05 | 377 | 56 | 7 | M40997 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 2.09e-05 | 723 | 56 | 9 | MM3672 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 3.73e-05 | 176 | 56 | 5 | MM1048 | |
| Coexpression | VERHAAK_AML_WITH_NPM1_MUTATED_UP | 4.98e-05 | 187 | 56 | 5 | M4861 | |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_UP | 5.51e-05 | 191 | 56 | 5 | M6180 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 6.38e-05 | 197 | 56 | 5 | M8672 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP | 6.69e-05 | 199 | 56 | 5 | M5266 | |
| Coexpression | GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP | 6.69e-05 | 199 | 56 | 5 | M9252 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN | 6.85e-05 | 200 | 56 | 5 | M4506 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_UP | 6.85e-05 | 200 | 56 | 5 | M4948 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN | 6.85e-05 | 200 | 56 | 5 | M4496 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN | 6.85e-05 | 200 | 56 | 5 | M4480 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN | 6.85e-05 | 200 | 56 | 5 | M4486 | |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN | 6.85e-05 | 200 | 56 | 5 | M3088 | |
| Coexpression | AIZARANI_LIVER_C31_KUPFFER_CELLS_5 | 1.28e-04 | 120 | 56 | 4 | M39130 | |
| Coexpression | AIZARANI_LIVER_C18_NK_NKT_CELLS_5 | 1.32e-04 | 121 | 56 | 4 | M39120 | |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_DN | 1.52e-04 | 237 | 56 | 5 | M4502 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | 1.62e-04 | 382 | 56 | 6 | M45756 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_MYELOID_CELLS | 1.84e-04 | 132 | 56 | 4 | M40289 | |
| Coexpression | DESCARTES_FETAL_HEART_MYELOID_CELLS | 2.07e-04 | 136 | 56 | 4 | M40196 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | DGCR2 LILRB3 FRMD6 SYNJ1 VCAN SCNN1A CLEC1B APOBEC1 PGM1 TMEM229B | 2.68e-04 | 1242 | 56 | 10 | M1920 |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP | 3.75e-04 | 159 | 56 | 4 | M12138 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_4_DN | 4.62e-04 | 15 | 56 | 2 | M2171 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_DN | 4.64e-04 | 302 | 56 | 5 | MM1046 | |
| Coexpression | AIZARANI_LIVER_C25_KUPFFER_CELLS_4 | 5.26e-04 | 174 | 56 | 4 | M39126 | |
| Coexpression | GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN | 6.76e-04 | 186 | 56 | 4 | M5855 | |
| Coexpression | GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP | 7.46e-04 | 191 | 56 | 4 | M6495 | |
| Coexpression | BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_TOP_FUNCTIONAL_NETWORK_POSITIVE | 7.49e-04 | 19 | 56 | 2 | M41054 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_UP | 8.06e-04 | 195 | 56 | 4 | M8737 | |
| Coexpression | GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP | 8.38e-04 | 197 | 56 | 4 | M8676 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN | 8.38e-04 | 197 | 56 | 4 | M8686 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP | 8.54e-04 | 198 | 56 | 4 | M5170 | |
| Coexpression | GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP | 8.54e-04 | 198 | 56 | 4 | M4309 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 8.86e-04 | 200 | 56 | 4 | M5851 | |
| Coexpression | GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN | 8.86e-04 | 200 | 56 | 4 | M4828 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 8.86e-04 | 200 | 56 | 4 | M5282 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP | 8.86e-04 | 200 | 56 | 4 | M5154 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP | 8.86e-04 | 200 | 56 | 4 | M8836 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_DC_DN | 8.86e-04 | 200 | 56 | 4 | M4484 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN | 8.86e-04 | 200 | 56 | 4 | M8682 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP | 8.86e-04 | 200 | 56 | 4 | M4347 | |
| Coexpression | GSE10325_BCELL_VS_MYELOID_DN | 8.86e-04 | 200 | 56 | 4 | M3082 | |
| CoexpressionAtlas | appendix | 4.26e-06 | 190 | 48 | 6 | appendix | |
| CoexpressionAtlas | spleen | 6.46e-06 | 315 | 48 | 7 | spleen | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | LILRA1 PPARGC1B LILRB3 LILRA2 LILRB2 VCAN LILRA6 CLEC1B LILRB1 | 3.01e-12 | 200 | 55 | 9 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-09 | 182 | 55 | 7 | 1fb9bdf2e9f0a9c230f109b471672f9c31e27c82 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-09 | 189 | 55 | 7 | 984b5f21e84dd8273d8437ac2a5a9de4e9484b9a | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-09 | 192 | 55 | 7 | 62eac1b8aed4fb924946b58c0237313f697a0136 | |
| ToppCell | URO|World / Disease, Lineage and Cell Type | 4.09e-09 | 193 | 55 | 7 | 421dc0996c6c973f88e90197b651255ae4dd13a2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.09e-09 | 193 | 55 | 7 | 52f5b0fbb8ca706206c65e7edbb1ddbd380aebae | |
| ToppCell | 390C-Myeloid-Monocyte-CD14+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.09e-09 | 193 | 55 | 7 | a50ee6110ea272d9d9f41d48bb5d43711cc00a32 | |
| ToppCell | (2)_Mono_macro|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.23e-09 | 194 | 55 | 7 | 7c05525614ee8cdfcbf22cce9146a8e73af7d14e | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.55e-09 | 196 | 55 | 7 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.71e-09 | 197 | 55 | 7 | 2d3547107c88c7443fc6425742694e13368a71f5 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.71e-09 | 197 | 55 | 7 | d9d58c2fe40d9b5b9031fb7a71525a535927effe | |
| ToppCell | wk_20-22-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.71e-09 | 197 | 55 | 7 | e862561f61a1ae1ec858b34f8d9c9a7dc8894104 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-iMON-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.88e-09 | 198 | 55 | 7 | a6aa113f0af4d25c032f440c3134fe4d88ca5055 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.88e-09 | 198 | 55 | 7 | 4ba72ba1f0cebc93053aae72d763c33e155b6fa4 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1_high|Mild / Condition, Lineage, Cell class and cell subclass | 4.88e-09 | 198 | 55 | 7 | 17aab4dc3b2cd6eb7dda77dd51bdc20490fcfe19 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.88e-09 | 198 | 55 | 7 | a0ceed8689d42be6b9cde89d6c182d10b3fb14fc | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 5.05e-09 | 199 | 55 | 7 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 5.05e-09 | 199 | 55 | 7 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | VE-granulo2|VE / Condition, Cell_class and T cell subcluster | 5.05e-09 | 199 | 55 | 7 | 05b47fdc01eccee0eaf4c781eeff93c47fe0533e | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 5.05e-09 | 199 | 55 | 7 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | VE-granulo2-|VE / Condition, Cell_class and T cell subcluster | 5.05e-09 | 199 | 55 | 7 | 455e92047201ddd0c29a437a838e5fa135de7995 | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 5.05e-09 | 199 | 55 | 7 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | 83d9aa5b46ae7a71a258b2e44b3251f95bc9a1b7 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | 47a3fd432c35958c5d478d34f5e0355e39ed0aba | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | 7076b0db66c8f90c8f9ccfbc8bc0dcc82b15e5f3 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD16|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | 94d7aa057a31287696a634d15ce91ce64af6455b | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | d237cf947d6768b022d18211e14af4adb4990708 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | 1aa4197f1c7c099313dc2e1f8b1153252add7a33 | |
| ToppCell | Biopsy_IPF-Immune-Monocytes|Biopsy_IPF / Sample group, Lineage and Cell type | 5.23e-09 | 200 | 55 | 7 | 80b2b7eecc5dce9d22f9c80562e4aea83bbf0f50 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | 0855ebb10b925664aa5cf813d97e97683c46180d | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Monocytic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-09 | 200 | 55 | 7 | 4077a85ceb8bb423c06179e16fd870ab95f8a2e8 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.62e-08 | 170 | 55 | 6 | 1c3c03821c90d41de92fef3278f71093a7fd709c | |
| ToppCell | Monocytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.62e-08 | 170 | 55 | 6 | 4e93b66b3033e6e4d5f6d2f41974623a53108f5e | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Non-cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.06e-07 | 184 | 55 | 6 | 324f91b70913bda3509e234aaf23b46fad91e076 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-07 | 184 | 55 | 6 | ba260f8a2e6e510141a6b9c458eb0040acff0352 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-07 | 186 | 55 | 6 | bec4767eaca28e41da373274704895eba75063e2 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.16e-07 | 187 | 55 | 6 | 23be50d81f4404a609dea821e1a66d221c0e0615 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 1.16e-07 | 187 | 55 | 6 | c20689022569640ebc4a878e3fe146b86fe9b386 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-07 | 187 | 55 | 6 | 8e1d6d25db5b5c91a651bb2d66edfcf073a31704 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-07 | 188 | 55 | 6 | 239bec13476dd43bebc2c6eba8d1fe35f2744673 | |
| ToppCell | Monocytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.24e-07 | 189 | 55 | 6 | 2164adbe1b0e8e4d39644546b7dfb19e9ea4f7b9 | |
| ToppCell | Monocytes-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.24e-07 | 189 | 55 | 6 | 22d08c7dde697f385100f72e009eeac8d19d329d | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-07 | 191 | 55 | 6 | 1c7d31684654ca6a046d8cc816af1fdc42369c57 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-07 | 191 | 55 | 6 | d60d81d2045c6e624bbc8b17e13a32f7921d969f | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-07 | 191 | 55 | 6 | 1e668d67bc254ea15518e2c7a029a61087609b7a | |
| ToppCell | 10x5'-blood|World / Manually curated celltypes from each tissue | 1.40e-07 | 193 | 55 | 6 | 359d4242a7e5e51a3eaf6fe51bc1c653a402b054 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.40e-07 | 193 | 55 | 6 | b044fca95f519ff2ceb378afe40a95911931a29e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-07 | 193 | 55 | 6 | c0509798ce06da0ec725c0c7b5cc195455f2c29f | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-07 | 194 | 55 | 6 | e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-07 | 195 | 55 | 6 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | 343B-Myeloid-Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-07 | 195 | 55 | 6 | 169b4952118ca5ded55de928a1cf08721cdac193 | |
| ToppCell | LAM-Myeloid-Monocyte|LAM / Condition, Lineage and Cell class | 1.49e-07 | 195 | 55 | 6 | 7ef400e068e730e18bbdb86f2daa7caf82602349 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.49e-07 | 195 | 55 | 6 | 580ed65b4152483b642a7e7dbdf00d03588c46f6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-07 | 195 | 55 | 6 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-07 | 195 | 55 | 6 | 01da7115e38c280fb0baff2032b62bdb609bad5e | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-07 | 195 | 55 | 6 | aa3914e277918299dc7d2995c0c72288462ad43d | |
| ToppCell | 390C-Myeloid-Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-07 | 195 | 55 | 6 | 6f09bfd6394c10c90c23d130a18941bf490e1a8f | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.54e-07 | 196 | 55 | 6 | 646a8d47dddffdfd2d8a62245ea6cd49f9510a1a | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.54e-07 | 196 | 55 | 6 | 7e136975e5943d42d51d8cc91c912547ef79cf4d | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-07 | 196 | 55 | 6 | 5842d6fa0c066815d7d8c7e59b192bfc72960707 | |
| ToppCell | proximal-3-Hematologic-Nonclassical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.54e-07 | 196 | 55 | 6 | e426d02c6bcff2358a45e627cc86389070a4af25 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.54e-07 | 196 | 55 | 6 | 376c5a459a484205fbb0db34936e4a6146d1f622 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-07 | 196 | 55 | 6 | 23e22dfb9f9aec17b83574295f889e75f46ded50 | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.54e-07 | 196 | 55 | 6 | 439d695526714772971fd1a4a92b8b6a84eee1a4 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-iMON-iMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-07 | 196 | 55 | 6 | 8608be3c3e7fd776c5f2fae207cd0b801e138349 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.54e-07 | 196 | 55 | 6 | f943519bff51c3094776fd45889dadf9062c8379 | |
| ToppCell | tumor_Lung-Myeloid_cells-Monocytes|tumor_Lung / Location, Cell class and cell subclass | 1.54e-07 | 196 | 55 | 6 | 4a00c416688ae06ed2aef19626a485f646925d67 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.54e-07 | 196 | 55 | 6 | aa53ae1e5d08d31cfd81b7fae46c2b5d21d4f9b2 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-07 | 197 | 55 | 6 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 1.58e-07 | 197 | 55 | 6 | 67f19dd30adb03300f04219d0295bc1c1788f626 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 1.58e-07 | 197 | 55 | 6 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | medial-Hematologic-Interstitial_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.58e-07 | 197 | 55 | 6 | b90c8a41e99c87b46be699d03cd49c97a2ad51af | |
| ToppCell | NS-control-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.58e-07 | 197 | 55 | 6 | 496a1115071a1be6928786192de49f3adf197dfb | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.58e-07 | 197 | 55 | 6 | ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-07 | 197 | 55 | 6 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 1.58e-07 | 197 | 55 | 6 | 98d4107e457e7399a84439acd73bf8f59598971b | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Non-cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.58e-07 | 197 | 55 | 6 | b843e9d664f909c1c12d72b93bd2b3279ca12a59 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.58e-07 | 197 | 55 | 6 | b91016249b3585aa3536e96af18e4f1b1d2d5ce4 | |
| ToppCell | 343B-Myeloid-Monocyte-CD16+_Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-07 | 197 | 55 | 6 | 8d6551e118cfe308088487c6d5171d986f90fb2f | |
| ToppCell | medial-Hematologic-Interstitial_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.58e-07 | 197 | 55 | 6 | 13aec816e21754eac590a12c3a9c795c41108277 | |
| ToppCell | COVID-19_Mild-Myeloid-Non-classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class | 1.58e-07 | 197 | 55 | 6 | 9c943d18f8e6cb0ce9f2158d50796fafae5c81d4 | |
| ToppCell | (7)_MNP|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.58e-07 | 197 | 55 | 6 | 6790346736946984cc80d67668523ba70ab0b380 | |
| ToppCell | medial-2-Hematologic-Interstitial_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.58e-07 | 197 | 55 | 6 | 38a74eeb2a4c8d6a86b133f02f4e6c641f16a3ac | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.63e-07 | 198 | 55 | 6 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 1.63e-07 | 198 | 55 | 6 | 2541f1095ed91e6789cb888cf39a208b8107726a | |
| ToppCell | Multiple_Sclerosis-Myeloid|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.63e-07 | 198 | 55 | 6 | 3c2817d95011ae372d0316ccf774e975536207b0 | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-07 | 198 | 55 | 6 | dbd7869483c5a67944cb94ced0ee2c7b999adc2e | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-07 | 198 | 55 | 6 | 8f64bb5cd8c3e2d5ef651821b0d59f67d1ca1a12 | |
| ToppCell | medial-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-07 | 198 | 55 | 6 | 432a26ace5b486695c9a933c0d44b73305b01ded | |
| ToppCell | URO-Myeloid|URO / Disease, Lineage and Cell Type | 1.63e-07 | 198 | 55 | 6 | 65a8879da871ddebeda945f312ea7c1065732040 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.63e-07 | 198 | 55 | 6 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | 10x5'-Liver-Myeloid_Monocytic|Liver / Manually curated celltypes from each tissue | 1.63e-07 | 198 | 55 | 6 | d0925948bf667545fb0b343e2fc80f7379e433e3 | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 1.63e-07 | 198 | 55 | 6 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2) | 1.63e-07 | 198 | 55 | 6 | d4eae333fa100db3ea2d4cbe7a1d6ab14816f0e2 | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|Healthy/Control / Disease group and Cell class | 1.63e-07 | 198 | 55 | 6 | 0badaf1fa5328d06291c3624d0f63196ffc81527 | |
| ToppCell | PBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.68e-07 | 199 | 55 | 6 | 02256d86541be6851634283047fdc05fdf095114 | |
| ToppCell | distal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.68e-07 | 199 | 55 | 6 | 5e209df67cfe8ac7437cc363f1c5c3166bfae1af | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Non-cla._mono.|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.68e-07 | 199 | 55 | 6 | 969f66a9adb337fa9857fb00bcace2d30c35a6a5 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD16|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-07 | 199 | 55 | 6 | 36662a76211162b1bf2d58dc819cae339f715c5f | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic|bone_marrow / Manually curated celltypes from each tissue | 1.68e-07 | 199 | 55 | 6 | 62b0861faf173eead75678aad10d396cd0d80c2c | |
| Computational | Neighborhood of TNFRSF1B | 6.53e-08 | 65 | 36 | 6 | GNF2_TNFRSF1B | |
| Computational | Neighborhood of CARD15 | 1.02e-07 | 70 | 36 | 6 | GNF2_CARD15 | |
| Computational | Neighborhood of HCK | 6.00e-07 | 94 | 36 | 6 | GNF2_HCK | |
| Computational | Neighborhood of CD33 | 7.32e-07 | 52 | 36 | 5 | GNF2_CD33 | |
| Computational | Neighborhood of PECAM1 | 1.07e-06 | 56 | 36 | 5 | GNF2_PECAM1 | |
| Computational | Neighborhood of CASP1 | 1.60e-06 | 111 | 36 | 6 | GNF2_CASP1 | |
| Computational | Genes in the cancer module 46. | LILRA1 LILRB3 LILRA2 MGST2 LILRB2 SKAP1 KIR3DL1 LILRB1 LILRB5 | 4.26e-06 | 394 | 36 | 9 | MODULE_46 |
| Computational | Immune response. | LILRA1 LILRB3 LILRA2 MGST2 LILRB2 SKAP1 KIR3DL1 LILRB1 LILRB5 | 4.62e-06 | 398 | 36 | 9 | MODULE_75 |
| Computational | Membranal receptors. | LILRA1 LILRB3 LILRA2 PTPRS LILRB2 GPR182 SKAP1 SCNN1A TACR3 KIR3DL1 | 4.97e-06 | 517 | 36 | 10 | MODULE_64 |
| Computational | Neighborhood of FOS | 9.82e-06 | 41 | 36 | 4 | GNF2_FOS | |
| Computational | Neighborhood of CD1D | 1.43e-05 | 45 | 36 | 4 | GNF2_CD1D | |
| Computational | Neighborhood of S100A4 | 1.71e-05 | 47 | 36 | 4 | GNF2_S100A4 | |
| Computational | Genes in the cancer module 27. | 1.76e-05 | 355 | 36 | 8 | MODULE_27 | |
| Computational | Genes in the cancer module 424. | 2.72e-05 | 18 | 36 | 3 | MODULE_424 | |
| Computational | Neighborhood of FGR | 1.60e-04 | 32 | 36 | 3 | GNF2_FGR | |
| Computational | Neighborhood of CD14 | 2.10e-04 | 35 | 36 | 3 | GNF2_CD14 | |
| Computational | Signaling. | LILRA1 LILRB3 VCAN GPR182 SKAP1 SCNN1A APOBEC1 TACR3 KIR3DL1 | 4.85e-04 | 723 | 36 | 9 | MODULE_117 |
| Computational | Porins / transporters. | 6.38e-04 | 211 | 36 | 5 | MODULE_63 | |
| Computational | Immune (defense) response. | 1.24e-03 | 142 | 36 | 4 | MODULE_223 | |
| Computational | Genes in the cancer module 478. | 1.80e-03 | 19 | 36 | 2 | MODULE_478 | |
| Computational | Whole blood genes. | 2.75e-03 | 581 | 36 | 7 | MODULE_45 | |
| Drug | IL-T | 3.13e-09 | 56 | 52 | 6 | CID000150551 | |
| Drug | LTC4 (leukotriene C4 | 1.70e-07 | 180 | 52 | 7 | CID000003907 | |
| Drug | alpha-bromo-4-chlorophenylacetic acid | 1.53e-05 | 3 | 52 | 2 | CID010490868 | |
| Drug | l-945 | 1.53e-05 | 3 | 52 | 2 | CID000097919 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 1.35e-08 | 15 | 54 | 4 | EFO_0008208 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 2 measurement | 9.46e-07 | 11 | 54 | 3 | EFO_0008209 | |
| Disease | early-onset Parkinson's disease (implicated_via_orthology) | 4.91e-05 | 6 | 54 | 2 | DOID:0060894 (implicated_via_orthology) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 4.91e-05 | 6 | 54 | 2 | EFO_0801767 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 4.91e-05 | 6 | 54 | 2 | EFO_0802705 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.98e-04 | 157 | 54 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | Down syndrome (implicated_via_orthology) | 3.40e-04 | 15 | 54 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | gamma-glutamylglutamine measurement | 7.42e-04 | 22 | 54 | 2 | EFO_0021138 | |
| Disease | malaria (is_implicated_in) | 8.84e-04 | 24 | 54 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | tuberculosis (is_implicated_in) | 1.21e-03 | 28 | 54 | 2 | DOID:399 (is_implicated_in) | |
| Disease | hepatitis C (is_implicated_in) | 1.21e-03 | 28 | 54 | 2 | DOID:1883 (is_implicated_in) | |
| Disease | Congenital disorder of glycosylation | 2.22e-03 | 38 | 54 | 2 | cv:C0282577 | |
| Disease | human immunodeficiency virus infectious disease (is_implicated_in) | 2.33e-03 | 39 | 54 | 2 | DOID:526 (is_implicated_in) | |
| Disease | interleukin 7 measurement | 3.09e-03 | 45 | 54 | 2 | EFO_0008189 | |
| Disease | interleukin 13 measurement | 3.09e-03 | 45 | 54 | 2 | EFO_0008171 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 3.66e-03 | 49 | 54 | 2 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | creatine kinase measurement | 5.26e-03 | 59 | 54 | 2 | EFO_0004534 | |
| Disease | squamous cell carcinoma | 6.74e-03 | 67 | 54 | 2 | EFO_0000707 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CFLWYYRVRHFFNNF | 101 | Q5SY80 | |
| FQGQCYKYFAHRRTW | 3176 | P13611 | |
| ASEYYHCWRNFVNYP | 146 | P41238 | |
| CFSRSLHYQFYVWYF | 351 | Q92685 | |
| YASWFESFCQFTHYR | 96 | Q8NEB7 | |
| HWQKYGRNFFTRYDY | 416 | P36871 | |
| SITWEHAGRYHCQYY | 86 | Q8N149 | |
| HWAKFGRHYYCRFDY | 421 | Q15124 | |
| CKASGYTFTYRYLHW | 41 | A0A0A0MS14 | |
| WALGNYHRFFRLYCH | 706 | Q96PV6 | |
| YRCFGSFRHSPYEWS | 291 | P43629 | |
| GSSRGCWYYLRYFFL | 16 | Q9BX97 | |
| YGCQYYSRARWSELS | 96 | Q8N423 | |
| RWSHRCYGYDLNSPY | 191 | Q8N423 | |
| RLYAYHLSRAAWYGG | 31 | Q9NY33 | |
| ADFGRTWHVYRYFSY | 166 | P55268 | |
| TWHVYRYFSYDCGAD | 171 | P55268 | |
| TPSCRWRFRCYYYYR | 186 | O75023 | |
| YRCHYYSSAGWSEPS | 96 | Q6PI73 | |
| VTPSHRWRFTCYYYY | 186 | Q6PI73 | |
| RWRFTCYYYYTNTPR | 191 | Q6PI73 | |
| YRCHYYSSAGWSEPS | 96 | O75022 | |
| VTPSHRWRFTCYYYY | 186 | O75022 | |
| WETHKDSSGRCYYYN | 271 | Q8IWW6 | |
| HQYWPAERSARYQYF | 1791 | Q13332 | |
| RLISDRAARYYYYWH | 121 | Q96NE9 | |
| GFYRAWHQVEYYRYI | 286 | Q9UK97 | |
| KWHYLCLRRYGYDSN | 56 | Q8WU20 | |
| RSIYNAAVWYYHHCQ | 141 | Q8TF46 | |
| ASCYRVYLSGENYWD | 126 | P98153 | |
| QYYCEYCWAAIHSRA | 691 | Q17RY0 | |
| LLYCNSSGAHWYYLF | 41 | Q17R55 | |
| YFGLRYCDRSHQTYW | 56 | Q9HCS5 | |
| NVEYCDYRKHSSWGY | 441 | P37088 | |
| CHWGQRFRYSYYDES | 191 | Q9Y316 | |
| CLGLVYIYGRHLYFW | 81 | Q99735 | |
| YLYKFRHSPNCWYLR | 91 | Q92552 | |
| YFDFRTYCKGRWVGH | 146 | Q8IZ73 | |
| SRWYLYAIHGYFCEV | 11 | Q8NBD8 | |
| SHDYVFWCGDFNYRI | 721 | O43426 | |
| FSHDYVFWCGDFNYR | 716 | O15056 | |
| RRWSYRCYAYDSNSP | 191 | O75019 | |
| PSITWEHAGRYRCYY | 86 | Q8NHL6 | |
| WGSFSCRFTHYFYFV | 121 | O15218 | |
| YRCFGSFRHSPYEWS | 291 | Q14943 | |
| YGGLRHFCWPRYTDY | 976 | Q86YN6 | |
| QNGDYTHFYFCYRWF | 901 | O43147 | |
| ALHSEWYFGANYCRF | 146 | P29371 | |
| TGWYKDLRHYYYRAR | 421 | P51688 | |
| FRTRHYAQAYYGWSL | 181 | P0DPD7 | |
| WRYYGDSCYGFFRHN | 106 | Q9P126 | |
| SWSTSYSGYRYHRHC | 86 | Q5M9Q1 | |
| WDRCRYYHDRYALYA | 1056 | Q9H9J4 | |
| YWCDAEYDAYRREHS | 1291 | O15027 | |
| RWYYNPFSEHCARFT | 406 | O43278 | |
| RCVPISNHLYFYWYR | 41 | A0A1B0GX68 | |
| WCALVGKIFYYYRSH | 706 | Q9ULM0 | |
| RWFVFDARRCYLYYF | 56 | Q9UPU7 | |
| RWCVVSRGLFYYYAN | 131 | Q86WV1 | |
| RHYTQFWNYLERCRY | 76 | O95407 | |
| WHYCDGYDRRFYTEI | 81 | Q5VZ52 |